A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma

Purpose: To evaluate the efficacy and toxicity of definitive concurrent chemoradiotherapy (CCRT) with docetaxel plus cisplatin (DP regimen) versus 5-fluorouracil plus cisplatin (PF regimen) in patients with oesophageal squamous cell carcinoma (ESCC). Patients and Methods: In this phase II randomized...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cancer
Glavni autori: Zhu, Yujia, Zhang, Wenwen, Li, Qiaoqiao, Li, Qiwen, Qiu, Bo, Liu, Hui, Liu, Mengzhong, Hu, Yonghong
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688918/
https://ncbi.nlm.nih.gov/pubmed/29151952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.20053
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items